Item 9.01 Financial Statements and Exhibits.
(d) Exhibits Exhibit No. Description 2.1* Business Combination Agreement, dated as ofMarch 15, 2021 , by and betweenTherapeutics Acquisition Corp. ,Bodhi Merger Sub, Inc. andPOINT BioPharma Inc. 10.1 Form of Sponsor Letter Agreement. * Certain exhibits and schedules to this Exhibit have been omitted in accordance with Item 601(a)(5) of Regulation S-K.The Company agrees to furnish supplementally a copy of any omitted exhibit or schedule to theSEC upon its request.
© Edgar Online, source